Abstract
The presence of resistant pathogens in the lower airways of patients with cystic fibrosis (CF) is not an absolute contraindication for lung transplantation. We describe a case in which a patient with CF died as a result of an anastomotic dehiscence, ischemia, and infection with linezolid-resistant methicillin-resistant Staphylococcus aureus. We review infection issues during the post-lung-transplant period and related anastomotic dehiscence in CF.
- anastamosis
- anastomotic failure
- anastomotic ischemia
- dehiscence
- cystic fibrosis
- CF
- lung transplantation
- linezolid
- resistant
- methicillin-resistant Staphylococcus aureus
- MRSA
- airway-pressure-release ventilation
Footnotes
- Correspondence: Don Hayes Jr MD, Lung Transplant Program, University of Kentucky Medical Center, 800 Rose Street, Lexington KY 40536-0293. E-mail: don.hayes{at}uky.edu.
The authors have disclosed no conflicts of interest.
- Copyright © 2010 by Daedalus Enterprises Inc.
